Insulet Corp. (PODD)
145.63
-2.53
(-1.71%)
USD |
NASDAQ |
Aug 24, 16:00
145.50
-0.13
(-0.09%)
After-Hours: 20:00
Insulet EPS Diluted (Quarterly) : 1.066 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.066 |
| March 31, 2026 | 1.298 |
| December 31, 2025 | 1.441 |
| September 30, 2025 | 1.240 |
| June 30, 2025 | 0.3185 |
| March 31, 2025 | 0.502 |
| December 31, 2024 | 1.386 |
| September 30, 2024 | 1.079 |
| June 30, 2024 | 2.589 |
| March 31, 2024 | 0.7336 |
| December 31, 2023 | 1.479 |
| September 30, 2023 | 0.7049 |
| June 30, 2023 | 0.3892 |
| March 31, 2023 | 0.3395 |
| December 31, 2022 | 0.2428 |
| September 30, 2022 | -0.0749 |
| June 30, 2022 | -0.5046 |
| March 31, 2022 | 0.398 |
| December 31, 2021 | 0.4182 |
| September 30, 2021 | 0.181 |
| June 30, 2021 | -0.3748 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.2593 |
| September 30, 2020 | 0.1736 |
| June 30, 2020 | 0.2196 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0334 |
| December 31, 2019 | 0.0783 |
| September 30, 2019 | 0.0137 |
| June 30, 2019 | 0.0228 |
| March 31, 2019 | 0.0716 |
| December 31, 2018 | 0.162 |
| September 30, 2018 | 0.0271 |
| June 30, 2018 | -0.0287 |
| March 31, 2018 | -0.1123 |
| December 31, 2017 | -0.12 |
| September 30, 2017 | -0.04 |
| June 30, 2017 | -0.13 |
| March 31, 2017 | -0.17 |
| December 31, 2016 | -0.16 |
| September 30, 2016 | -0.05 |
| June 30, 2016 | -0.0734 |
| March 31, 2016 | -0.241 |
| December 31, 2015 | -0.48 |
| September 30, 2015 | -0.34 |
| June 30, 2015 | -0.27 |
| March 31, 2015 | -0.21 |
| December 31, 2014 | -0.10 |
| September 30, 2014 | -0.19 |
| June 30, 2014 | -0.53 |
| March 31, 2014 | -0.11 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5324 |
| DexCom, Inc. | 0.6429 |
| Boston Scientific Corp. | 0.615 |
| PROCEPT BioRobotics Corp. | -0.4707 |
| Globus Medical, Inc. | 1.103 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 95.00M |
| Revenue (Quarterly) | 801.70M |
| Total Expenses (Quarterly) | 706.70M |
| Enterprise Value | 10.69B |
| Gross Profit Margin (Quarterly) | 72.56% |
| Profit Margin (Quarterly) | 11.85% |
| Earnings Yield | 3.46% |
| Operating Earnings Yield | 5.04% |
| Normalized Earnings Yield | 3.402 |